What are the major opportunities in the Artificial Intelligence (AI) In Respiratory Diseases market? What are the strategies for the Artificial Intelligence (AI) In Respiratory Diseases market?

For detailed insights on the major opportunities and strategies in the Artificial Intelligence (AI) In Respiratory Diseases market, Read More

How does the Artificial Intelligence (AI) In Respiratory Diseases market relate to the overall economy and other similar markets?

For detailed insights on Artificial Intelligence (AI) In Respiratory Diseases's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Artificial Intelligence (AI) In Respiratory Diseases market growth? SWOT analysis of the Artificial Intelligence (AI) In Respiratory Diseases market.

For detailed insights on the key dynamics influencing the Artificial Intelligence (AI) In Respiratory Diseases market growth and SWOT analysis of the Artificial Intelligence (AI) In Respiratory Diseases industry, Read More

Artificial Intelligence (AI) In Respiratory Diseases Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Artificial Intelligence (AI) In Respiratory Diseases Market Report 2026

Name: Artificial Intelligence (AI) In Respiratory Diseases Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Imaging Type (Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)), By Indication (Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection), By End Use (Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Artificial Intelligence (AI) In Respiratory Diseases Market Overview

• Artificial Intelligence (AI) In Respiratory Diseases market size has reached to $7.98 billion in 2025

• Expected to grow to $10.19 billion in 2030 at a compound annual growth rate (CAGR) of 5%

• Growth Driver: AI Revolutionizing Respiratory Health Addressing The Impact Of Growing Environmental Pollution

• Market Trend: TidalSense Launches N-Tidal Device For AI-Driven Respiratory Disease Management

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Artificial Intelligence (AI) In Respiratory Diseases Market?

Artificial intelligence (AI) in respiratory diseases refers to the use of AI and machine learning techniques to aid clinicians in the diagnosis, management, and treatment of various respiratory conditions. It has numerous potential applications in pulmonary medicine, including image analysis, predictive modeling, and disease management.

The main imaging types of artificial intelligence (AI) in respiratory diseases are magnetic resonance imaging (MRI), computed tomography (CT) scan, and electronic patient-reported outcomes (ePRO). AI in chronic obstructive pulmonary disease refers to the application of artificial intelligence (AI) technologies in the diagnosis, management, and treatment of COPD. It is used for the treatment of various indications such as chronic obstructive pulmonary disease, interstitial lung disease, and pulmonary infection, by several end-users, including hospital, diagnostic centers, ambulatory surgical centers, and others.

Artificial Intelligence (AI) In Respiratory Diseases Market Global Report 2026 Market Report bar graph

What Is The Artificial Intelligence (AI) In Respiratory Diseases Market Size and Share 2026?

The artificial intelligence (ai) in respiratory diseases market size has grown steadily in recent years. It will grow from $7.98 billion in 2025 to $8.38 billion in 2026 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to rising incidence of respiratory diseases, increased use of ct and mri imaging, growing digitalization of healthcare records, early adoption of ai-assisted diagnostics, expansion of hospital diagnostic capabilities.

What Is The Artificial Intelligence (AI) In Respiratory Diseases Market Growth Forecast?

The artificial intelligence (ai) in respiratory diseases market size is expected to see strong growth in the next few years. It will grow to $10.19 billion in 2030 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to increasing demand for personalized respiratory care, rising integration of ai with clinical decision support systems, expansion of remote monitoring for chronic respiratory patients, growing focus on preventive pulmonology, advancements in medical imaging ai. Major trends in the forecast period include increasing use of AI-based imaging analysis, rising adoption of predictive disease progression models, growing integration of ai in pulmonary diagnostics, expansion of remote respiratory monitoring solutions, enhanced focus on early disease detection.

Book your 30 minutes free consultation with our research experts

Global Artificial Intelligence (AI) In Respiratory Diseases Market Segmentation

1) By Imaging Type: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)

2) By Indication: Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection

3) By End Use: Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Magnetic Resonance Imaging (MRI): Lung Imaging, Thoracic Imaging, Cardiopulmonary Imaging

2) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT), Low-Dose CT, Thoracic CT

3) By Electronic Patient-Reported Outcomes (ePRO): Symptom Tracking, Medication Adherence Monitoring, Quality Of Life Assessments

What Is The Driver Of The Artificial Intelligence (AI) In Respiratory Diseases Market?

respiratory disease market going forward. Environmental pollution refers to the addition of any substance or form of energy to the environment at a rate faster than it can be dispersed or stored in a harmless form. AI in respiratory diseases has the potential to significantly reduce the impact of environmental pollution on respiratory health by offering real-time monitoring, personalized risk assessments, informed decision-making, and innovative solutions for both individuals and communities. For instance, in November 2024, according to the Global Carbon Budget, a Japan-based annual scientific assessment, fossil carbon dioxide emissions climbed to 37.4 billion tonnes, an increase of 0.8% over the previous year. Therefore, growing environmental pollution is driving the growth of artificial intelligence (AI) in the respiratory disease market.

Key Players In The Global Artificial Intelligence (AI) In Respiratory Diseases Market

Major companies operating in the artificial intelligence (AI) in respiratory diseases market are Siemens Healthineers, Philips Healthcare, GE Healthcare, Verily Life Sciences LLC, DeepMind Health, Merative L.P., Aidoc Medical, Butterfly Network, Infervision, Imagen Technologies, Caption Health, Swaasa AI, VIDA Diagnostics Inc., Enlitic, Thirona B.V., ArtiQ, Icometrix, Aidence, Arterys, PneumoWave Ltd

Global Artificial Intelligence (AI) In Respiratory Diseases Market Trends and Insights

Major companies operating in artificial intelligence (AI) in the respiratory diseases market are developing innovative products such as N-Tidal devices to monitor patients' tidal breathing. The n-Tidal device measures the volume of air exchanged during normal breathing and provides valuable information about lung function. For instance, in August 2023, TidalSense, a UK-based respiratory technology company, launched N-Tidal, a regulated AI technology for chronic obstructive pulmonary disease (COPD) diagnosis and management. The technology combines N-Tidal's CO2 sensor data with an artificial intelligence platform to measure changes in lung function, aiming to improve the diagnosis and management of this respiratory condition. Clinical studies have demonstrated the technology's high accuracy, and it is expected to reform the diagnostic process for respiratory diseases. The launch is a significant development in the use of AI for respiratory disease assessment, offering a more comfortable and efficient alternative to existing diagnostic tests.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Artificial Intelligence (AI) In Respiratory Diseases Market?

In July 2023, ResMed Inc., a US-based medical equipment company that provides cloud-connectable medical devices, acquired Somnoware for an undisclosed amount. This acquisition strengthens ResMed's sleep and respiratory care portfolio and complements its existing digital respiratory healthcare tools. The acquisition is expected to enhance the management of patient data, ordering of treatment equipment, scheduling appointments, and tracking compliance, ultimately improving patient experience and health outcomes. Somnoware is a US-based, cloud-based platform for enhanced respiratory care management and hospital-at-home care.

Regional Outlook

North America was the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Artificial Intelligence (AI) In Respiratory Diseases Market?

The artificial Intelligence (AI) in respiratory diseases market includes revenues earned by entities by providing services such as AI-assisted imaging analysis, digital pathology platforms, and AI-powered rehabilitation programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in respiratory diseases market also includes sales IoT devices, wearables, and smart inhalers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Artificial Intelligence (AI) In Respiratory Diseases Market Report 2026?

The artificial intelligence (ai) in respiratory diseases market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (ai) in respiratory diseases industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Artificial Intelligence (AI) In Respiratory Diseases Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$8.38 billion
Revenue Forecast In 2035	$10.19 billion
Growth Rate	CAGR of 4.9% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Imaging Type, Indication, End Use
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Siemens Healthineers, Philips Healthcare, GE Healthcare, Verily Life Sciences LLC, DeepMind Health, Merative L.P., Aidoc Medical, Butterfly Network, Infervision, Imagen Technologies, Caption Health, Swaasa AI, VIDA Diagnostics Inc., Enlitic, Thirona B.V., ArtiQ, Icometrix, Aidence, Arterys, PneumoWave Ltd
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Artificial Intelligence (AI) In Respiratory Diseases Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Artificial Intelligence (AI) In Respiratory Diseases Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Artificial Intelligence (AI) In Respiratory Diseases Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Artificial Intelligence (AI) In Respiratory Diseases Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Artificial Intelligence & Autonomous Intelligence

4.1.2 Biotechnology, Genomics & Precision Medicine

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Increasing Use Of Ai-Based Imaging Analysis

4.2.2 Rising Adoption Of Predictive Disease Progression Models

4.2.3 Growing Integration Of Ai In Pulmonary Diagnostics

4.2.4 Expansion Of Remote Respiratory Monitoring Solutions

4.2.5 Enhanced Focus On Early Disease Detection

5. Artificial Intelligence (AI) In Respiratory Diseases Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Diagnostic Centers

5.3 Ambulatory Surgical Centers

5.4 Pulmonology Clinics

5.5 Research Institutes

6. Artificial Intelligence (AI) In Respiratory Diseases Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Artificial Intelligence (AI) In Respiratory Diseases Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Artificial Intelligence (AI) In Respiratory Diseases PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Artificial Intelligence (AI) In Respiratory Diseases Market Size, Comparisons And Growth Rate Analysis

7.3. Global Artificial Intelligence (AI) In Respiratory Diseases Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Artificial Intelligence (AI) In Respiratory Diseases Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Artificial Intelligence (AI) In Respiratory Diseases Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Artificial Intelligence (AI) In Respiratory Diseases Market Segmentation

9.1. Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)

9.2. Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection

9.3. Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users

9.4. Global Artificial Intelligence (AI) In Respiratory Diseases Market, Sub-Segmentation Of Magnetic Resonance Imaging (MRI), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Lung Imaging, Thoracic Imaging, Cardiopulmonary Imaging

9.5. Global Artificial Intelligence (AI) In Respiratory Diseases Market, Sub-Segmentation Of Computed Tomography (CT) Scan, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

High-Resolution CT (HRCT), Low-Dose CT, Thoracic CT

9.6. Global Artificial Intelligence (AI) In Respiratory Diseases Market, Sub-Segmentation Of Electronic Patient-Reported Outcomes (ePRO), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Symptom Tracking, Medication Adherence Monitoring, Quality Of Life Assessments

10. Artificial Intelligence (AI) In Respiratory Diseases Market Regional And Country Analysis

10.1. Global Artificial Intelligence (AI) In Respiratory Diseases Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Artificial Intelligence (AI) In Respiratory Diseases Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Artificial Intelligence (AI) In Respiratory Diseases Market

11.1. Asia-Pacific Artificial Intelligence (AI) In Respiratory Diseases Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Segmentation By Indication, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Artificial Intelligence (AI) In Respiratory Diseases Market

12.1. China Artificial Intelligence (AI) In Respiratory Diseases Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Segmentation By Indication, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Artificial Intelligence (AI) In Respiratory Diseases Market

13.1. India Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Segmentation By Indication, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Artificial Intelligence (AI) In Respiratory Diseases Market

14.1. Japan Artificial Intelligence (AI) In Respiratory Diseases Market Overview

14.2. Japan Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Segmentation By Indication, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Artificial Intelligence (AI) In Respiratory Diseases Market

15.1. Australia Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Segmentation By Indication, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Artificial Intelligence (AI) In Respiratory Diseases Market

16.1. Indonesia Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Segmentation By Indication, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Artificial Intelligence (AI) In Respiratory Diseases Market

17.1. South Korea Artificial Intelligence (AI) In Respiratory Diseases Market Overview

17.2. South Korea Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Segmentation By Indication, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Artificial Intelligence (AI) In Respiratory Diseases Market

18.1. Taiwan Artificial Intelligence (AI) In Respiratory Diseases Market Overview

18.2. Taiwan Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Segmentation By Indication, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Artificial Intelligence (AI) In Respiratory Diseases Market

19.1. South East Asia Artificial Intelligence (AI) In Respiratory Diseases Market Overview

19.2. South East Asia Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Segmentation By Indication, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Artificial Intelligence (AI) In Respiratory Diseases Market

20.1. Western Europe Artificial Intelligence (AI) In Respiratory Diseases Market Overview

20.2. Western Europe Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Segmentation By Indication, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Artificial Intelligence (AI) In Respiratory Diseases Market

21.1. UK Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Segmentation By Indication, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Artificial Intelligence (AI) In Respiratory Diseases Market

22.1. Germany Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Segmentation By Indication, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Artificial Intelligence (AI) In Respiratory Diseases Market

23.1. France Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Segmentation By Indication, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Artificial Intelligence (AI) In Respiratory Diseases Market

24.1. Italy Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Segmentation By Indication, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Artificial Intelligence (AI) In Respiratory Diseases Market

25.1. Spain Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Segmentation By Indication, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Artificial Intelligence (AI) In Respiratory Diseases Market

26.1. Eastern Europe Artificial Intelligence (AI) In Respiratory Diseases Market Overview

26.2. Eastern Europe Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Segmentation By Indication, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Artificial Intelligence (AI) In Respiratory Diseases Market

27.1. Russia Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Segmentation By Indication, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Artificial Intelligence (AI) In Respiratory Diseases Market

28.1. North America Artificial Intelligence (AI) In Respiratory Diseases Market Overview

28.2. North America Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Segmentation By Indication, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Artificial Intelligence (AI) In Respiratory Diseases Market

29.1. USA Artificial Intelligence (AI) In Respiratory Diseases Market Overview

29.2. USA Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Segmentation By Indication, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Artificial Intelligence (AI) In Respiratory Diseases Market

30.1. Canada Artificial Intelligence (AI) In Respiratory Diseases Market Overview

30.2. Canada Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Segmentation By Indication, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Artificial Intelligence (AI) In Respiratory Diseases Market

31.1. South America Artificial Intelligence (AI) In Respiratory Diseases Market Overview

31.2. South America Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Segmentation By Indication, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Artificial Intelligence (AI) In Respiratory Diseases Market

32.1. Brazil Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Segmentation By Indication, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Artificial Intelligence (AI) In Respiratory Diseases Market

33.1. Middle East Artificial Intelligence (AI) In Respiratory Diseases Market Overview

33.2. Middle East Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Segmentation By Indication, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Artificial Intelligence (AI) In Respiratory Diseases Market

34.1. Africa Artificial Intelligence (AI) In Respiratory Diseases Market Overview

34.2. Africa Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Segmentation By Indication, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Artificial Intelligence (AI) In Respiratory Diseases Market Regulatory and Investment Landscape

36. Artificial Intelligence (AI) In Respiratory Diseases Market Competitive Landscape And Company Profiles

36.1. Artificial Intelligence (AI) In Respiratory Diseases Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Artificial Intelligence (AI) In Respiratory Diseases Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Artificial Intelligence (AI) In Respiratory Diseases Market Company Profiles

36.3.1. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Philips Healthcare Overview, Products and Services, Strategy and Financial Analysis

36.3.3. GE Healthcare Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Verily Life Sciences LLC Overview, Products and Services, Strategy and Financial Analysis

36.3.5. DeepMind Health Overview, Products and Services, Strategy and Financial Analysis

37. Artificial Intelligence (AI) In Respiratory Diseases Market Other Major And Innovative Companies

Merative L.P., Aidoc Medical, Butterfly Network, Infervision, Imagen Technologies, Caption Health, Swaasa AI, VIDA Diagnostics Inc., Enlitic, Thirona B.V., ArtiQ, Icometrix, Aidence, Arterys, PneumoWave Ltd

38. Global Artificial Intelligence (AI) In Respiratory Diseases Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Artificial Intelligence (AI) In Respiratory Diseases Market

40. Artificial Intelligence (AI) In Respiratory Diseases Market High Potential Countries, Segments and Strategies

40.1 Artificial Intelligence (AI) In Respiratory Diseases Market In 2030 - Countries Offering Most New Opportunities

40.2 Artificial Intelligence (AI) In Respiratory Diseases Market In 2030 - Segments Offering Most New Opportunities

40.3 Artificial Intelligence (AI) In Respiratory Diseases Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Overview Of Key Products - Product Examples

Table 2: Global Artificial Intelligence (AI) In Respiratory Diseases Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Supply Chain Analysis

Table 4: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Major Raw Material Providers

Table 5: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Major Resource Providers

Table 6: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Major Manufacturers (Suppliers)

Table 7: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Major Distributors And Channel Partners

Table 8: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Key Technologies & Future Trends

Table 9: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Major Trends

Table 10: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Major End Users

Table 11: Global Artificial Intelligence (AI) In Respiratory Diseases Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Artificial Intelligence (AI) In Respiratory Diseases Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Artificial Intelligence (AI) In Respiratory Diseases Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Artificial Intelligence (AI) In Respiratory Diseases Market - TAM, US$ Billion, 2025

Table 15: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Sub-Segmentation Of Magnetic Resonance Imaging (MRI), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Sub-Segmentation Of Computed Tomography (CT) Scan, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Sub-Segmentation Of Electronic Patient-Reported Outcomes (ePRO), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Global Artificial Intelligence (AI) In Respiratory Diseases Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 96: Global Artificial Intelligence (AI) In Respiratory Diseases Market - Company Scoring Matrix

Table 97: Siemens Healthineers Financial Performance

Table 98: Philips Healthcare Financial Performance

Table 99: GE Healthcare Financial Performance

Table 100: Verily Life Sciences LLC Financial Performance

Table 101: DeepMind Health Financial Performance

Table 102: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Competitive Benchmarking (In USD Billions)

Table 103: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Competitive Dashboard

Table 104: Global Artificial Intelligence (AI) In Respiratory Diseases Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 105: Global, Artificial Intelligence (AI) In Respiratory Diseases Market Size Gain ($ Billion), Segmentation By Imaging Type, 2025 – 2030

Table 106: Global, Artificial Intelligence (AI) In Respiratory Diseases Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

Table 107: Global, Artificial Intelligence (AI) In Respiratory Diseases Market Size Gain ($ Billion), Segmentation By End Use, 2025 – 2030

List Of Figures

Figure 1: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Overview Of Key Products - Product Examples

Figure 2: Global Artificial Intelligence (AI) In Respiratory Diseases Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Supply Chain Analysis

Figure 4: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Major Raw Material Providers

Figure 5: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Major Resource Providers

Figure 6: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Major Manufacturers (Suppliers)

Figure 7: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Major Distributors And Channel Partners

Figure 8: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Key Technologies & Future Trends

Figure 9: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Major Trends

Figure 10: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Major End Users

Figure 11: Global Artificial Intelligence (AI) In Respiratory Diseases Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Artificial Intelligence (AI) In Respiratory Diseases Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Artificial Intelligence (AI) In Respiratory Diseases Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Artificial Intelligence (AI) In Respiratory Diseases Market - TAM, US$ Billion, 2025

Figure 15: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Sub-Segmentation Of Magnetic Resonance Imaging (MRI), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Sub-Segmentation Of Computed Tomography (CT) Scan, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Sub-Segmentation Of Electronic Patient-Reported Outcomes (ePRO), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Global Artificial Intelligence (AI) In Respiratory Diseases Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 96: Global Artificial Intelligence (AI) In Respiratory Diseases Market - Company Scoring Matrix

Figure 97: Siemens Healthineers Financial Performance

Figure 98: Philips Healthcare Financial Performance

Figure 99: GE Healthcare Financial Performance

Figure 100: Verily Life Sciences LLC Financial Performance

Figure 101: DeepMind Health Financial Performance

Figure 102: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Competitive Benchmarking (In USD Billions)

Figure 103: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Competitive Dashboard

Figure 104: Global Artificial Intelligence (AI) In Respiratory Diseases Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 105: Global, Artificial Intelligence (AI) In Respiratory Diseases Market Size Gain ($ Billion), Segmentation By Imaging Type, 2025 – 2030

Figure 106: Global, Artificial Intelligence (AI) In Respiratory Diseases Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

Figure 107: Global, Artificial Intelligence (AI) In Respiratory Diseases Market Size Gain ($ Billion), Segmentation By End Use, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Artificial Intelligence In Medicine Market Report 2026 - Global Outlook – By Type (Hardware, Software, Services), By Technology (Machine Learning, Natural Language Processing, Context-Aware Processing, Computer Vision), ...

Artificial Intelligence (AI) in Precision Medicine Market Report 2026 - Global Outlook – By Component (Hardware, Software, Service), By Technology (Deep Learning, Querying Method, Natural Language Processing, Context Awa...

Artificial Intelligence In The Diagnostic Market Report 2026 - Global Outlook – By Component (Hardware, Software, Services), By Technology (Machine Learning, NLP (Natural Language Processing), Context-Aware Computing, Co...

Artificial Intelligence (AI) In Respiratory Diseases Market Report 2026 - Global Outlook – By Imaging Type (Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)), B...

Artificial Intelligence in Healthcare Diagnosis Market Report 2026 - Global Outlook – By Component (Software, Services, Hardware), By Diagnosis (Cardiology, Oncology, Pathology, Radiology, Chest And Lung, Neurology, Othe...

AI In Medical Diagnostics Market Report 2026 - Global Outlook – By Component (Software, Services), By Technology (Natural Language Processing, Computer Vision, Machine Learning, Context-Aware Computing, Other Technologie...

Artificial Intelligence (AI) In Animal Health Market Report 2026 - Global Outlook – By Solution (Hardware, Software And Services), By Technology (Machine Learning, Natural Language Processing (NLP), Computer Vision, Othe...

Frequently Asked Questions

What is the projected market size of the Artificial Intelligence (AI) In Respiratory Diseases Market Report 2026 market by 2030?

The Artificial Intelligence (AI) In Respiratory Diseases Market Report 2026 market was valued at $7.98 billion in 2025, increased to $8.38 billion in 2026, and is projected to reach $10.19 billion by 2030. request a sample here

What is the expected CAGR for the Artificial Intelligence (AI) In Respiratory Diseases Market Report 2026 market during the forecast period 2025 - 2030?

The expected CAGR for the Artificial Intelligence (AI) In Respiratory Diseases Market Report 2026 market during the forecast period 2025–2030 is 5.0%. request a sample here

What are the key factors driving the Artificial Intelligence (AI) In Respiratory Diseases Market Report 2026 market?

Major growth driver of the market includes: AI Revolutionizing Respiratory Health Addressing The Impact Of Growing Environmental Pollution in the Artificial Intelligence (AI) In Respiratory Diseases Market Report 2026 market. For further insights on this market, request a sample here

Which end-use segment are covered in the Artificial Intelligence (AI) In Respiratory Diseases Market Report 2026 market report?

The artificial intelligence (AI) in respiratory diseases market covered in this report is segmented –
1) By Imaging Type: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)
2) By Indication: Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection
3) By End Use: Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users Subsegments:
1) By Magnetic Resonance Imaging (MRI): Lung Imaging, Thoracic Imaging, Cardiopulmonary Imaging
2) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT), Low-Dose CT, Thoracic CT
3) By Electronic Patient-Reported Outcomes (ePRO): Symptom Tracking, Medication Adherence Monitoring, Quality Of Life Assessments request a sample here

What is the anticipated growth trend for the Artificial Intelligence (AI) In Respiratory Diseases Market Report 2026 market?

Major trend in this market includes: TidalSense Launches N-Tidal Device For AI-Driven Respiratory Disease Management For further insights on this market, request a sample here.

Who are the key players in the Artificial Intelligence (AI) In Respiratory Diseases Market Report 2026 market?

Major companies operating in the Artificial Intelligence (AI) In Respiratory Diseases Market Report 2026 market are Major companies operating in the artificial intelligence (AI) in respiratory diseases market are Siemens Healthineers, Philips Healthcare, GE Healthcare, Verily Life Sciences LLC, DeepMind Health, Merative L.P., Aidoc Medical, Butterfly Network, Infervision, Imagen Technologies, Caption Health, Swaasa AI, VIDA Diagnostics Inc., Enlitic, Thirona B.V., ArtiQ, Icometrix, Aidence, Arterys, PneumoWave Ltd request a sample here.

Which region has the most growth potential in the Artificial Intelligence (AI) In Respiratory Diseases Market Report 2026 market?

North America was the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in respiratory diseases market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.